Breast Cancer Index® and new data on its power to predict extended endocrine therapy benefit presented at ASCO 2019
June 03, 2019 08:00 ET
|
Biotheranostics, Inc.
San Diego, CA, June 03, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announces new pivotal data on the Breast Cancer Index® (BCI) being presented at the ASCO conference June 3, 2019 that further...
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
May 31, 2019 08:00 ET
|
Helsinn Healthcare S.A.
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 The NEPA IV formulation was evaluated for safety in the AC setting. Lugano,...